XBiotech (XBIT) Announces Launch of S. Aureus Infections Therapy
Tweet Send to a Friend
XBiotech (NASDAQ: XBIT) announced that the Food and Drug Administration (FDA) has lifted its clinical hold from the Company's IND ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE